Shenzhen Noposion Faces Evaluation Shift Amid Declining Sales and Profit Challenges

Shenzhen Noposion Crop Science Co., Ltd., a midcap player in the Chemicals & Petrochemicals industry, has recently undergone an adjustment in evaluation. This revision reflects a shift in the company's technical indicators, which have transitioned from a bullish stance to a mildly bullish outlook. Key financial metrics indicate that the company has faced challenges, particularly in its most recent quarter ending September 2025, where net sales reached CNY 407.38 million, marking a notable low. Additionally, the operating profit for the same period was recorded at CNY -91.36 million, resulting in an operating profit margin of -22.43%. Over the past five years, the company has experienced a modest annual growth rate in net sales of 5.64%, while operating profit has grown at a rate of 27.17%. Despite being net-debt free, the company's return on equity averages 11.01%, suggesting limited profitability relative to shareholders' funds. Furthermore, Shenzhen Noposion has underperformed the broader market, generating a return of 12.91% over the last year compared to the China Shanghai Composite's 24.98%. For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.